REFERENCES
- Llovet JM, Burroughs, Bruix J. Hepatocellular carcinoma. Lancet 2003; 362(9399)1907–1917, [PUBMED], [INFOTRIEVE]
- Bolondi L. Screening for hepatocellular carcinoma in cirrhosis. J. Hepatol. 2003; 39(4)1076–1084, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Sangiovanni A, Del Ninno E, Fasani P, De Fazio C, Ronchi G, Romeo R, Morabito A, De Franchis R, Colombo M. Increased survival of cirrhotic patients with hepatocellular carcinoma detected during surveillance. Gastroenterology 2004; 126(4)1005–1014, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Aach RD, Stevens CE, Hollinger FB, Mosley JW, Peterson DA, Taylor PE, Johnson RG, Barbosa LH, Nemo GJ. Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays. N Engl J Med 1991; 325(19)1325–1329, [PUBMED], [INFOTRIEVE]
- Borgna-Pignatti C, Rugolotto S, De Stefano P, Zhao H, Cappellini MD, Del Vecchio GC, Romeo MA, Forni GL, Gamberini MR, Ghilardi R, Piga A, Cnaan A. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica 2004; 89(10)1187–1193, [PUBMED], [INFOTRIEVE]
- Borgna-Pignatti C, Vergine G, Lombardo T, Cappellini MD, Cianciulli P, Maggio A, Renda D, Lai ME, Mandas A, Forni G, Piga A, Bisconte MG. Hepatocellular carcinoma in the thalassaemia syndromes. Br J Haematol 2004; 124(1)114–117, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Mancuso A, Rigano P, Renda D, Di Salvo V, Pignatti CB, Guddo F, Buccellato A, Nicoli N, Maggio A. Hepatocellular carcinoma on cirrhosis-free liver in a HCV-infected thalassemic. Am J Hematol 2005; 78(2)158–159, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, Christensen E, Pagliaro L, Colombo M, Rodes J. EASL Panel of Experts on HCC. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL Conference. European Association for the Study of the Liver. J Hepatol 2001; 35(3)421–430, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Borgna-Pignatti C, De Stefano P, Sessa F, Avato F. Hepatocellular carcinoma in thalassemia major. Med Pediatr Oncol 1986; 14(6)327–328, [PUBMED], [INFOTRIEVE]
- Kowdley KV. Iron, hemochromatosis, and hepatocellular carcinoma. Gastroenterology 2004; 127S1(9399)79–86, [CROSSREF]
- Elmberg M, Hultcrantz R, Ekbom A, Brandt L, Olsson S, Olsson R, Lindgren S, Loof L, Stal P, Wallerstedt S, Almer S, Sandberg-Gertzen H, Askling J. Cancer risk in patients with hereditary hemochromatosis and in their first-degree relatives. Gastroenterology 2003; 125(6)1733–1741, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Maggio A, D'Amico G, Morabito A, Capra M, Ciaccio C, Cianciulli P, Di Gregorio F, Garozzo G, Malizia R, Magnano C, Mangiagli A, Quarta G, Rizzo M, D'Ascola DG, Rizzo A, Midiri M. Deferiprone versus deferoxamine in patients with thalassemia major: a randomized clinical trial. Blood Cells Mol Dis 2002; 28(2)196–208, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Congia M, Clemente MG, Dessi C, Cucca F, Mazzoleni AP, Frau F, Lampis R, Cao A, Lai ME, De Virgiliis S. HLA class II genes in chronic hepatitis C virus-infection and associated immunological disorders. Hepatology 1996; 24(6)1338–1341, [PUBMED], [INFOTRIEVE]
- Prati D, Zanella A, Farma E, De Mattei C, Bosoni P, Zappa M, icone A, Mozzi F, Rebulla P, Cappellini MD, Allain JP, Sirchia G. A multicenter prospective study on the risk of acquiring liver disease in anti-hepatitis C virus negative patients affected from homozygous β-thalassemia. Blood 1998; 92(9)3460–3464, [PUBMED], [INFOTRIEVE]
- Olivieri NF, Liu PP, Sher GD, Daly PA, Greig PD, McCusker PJ, Collins AF, Francombe WH, Templeton DM, Butany J. Brief report: Combined liver and heart transplantation for end-stage iron-induced organ failure in an adult with homozygous β-thalassemia. N Engl J Med 1994; 330(16)1125–1127, [PUBMED], [INFOTRIEVE], [CROSSREF]